1차 및 2차 항결핵제에 의한 DRESS (drug reaction with eosinophilia and systemic symptom) 증후군 1예와 문헌고찰
DRESS (drug reaction with eosinophilia and systemic symptom) syndrome caused by both first-line and second-line antitubercular medications: A case report with a brief literature review
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially fatal drug-induced systemic hypersensitivity response characterized by erythematous eruption, fever, leukocytosis with eosinophilia, and internal organ involvement. Antitubercular agents are potential causative agents for DRESS syndrome but difficult to verify as a culprit drug, since antitubercular agents are coadministered as a combination regimen. A 42-year-old female with endobronchial tuberculosis was diagnosed with DRESS syndrome after 4-week treatment of isoniazid, rifampicin, ethambutol, and pyrazinamide with prednisolone 50 mg. All the antitubercular agents were stopped and replaced with levofloxacin, cycloserine, p-aminosalicylic acid, and kanamycin. However, severe exacerbation of DRESS syndrome compelled the patient to discontinue the administration of the second-line antitubercular agents. Two months later, the patient underwent a patch test for all the antitubercular agents which had been used, and the results showed positivity to isoniazid and cycloserine. We report a rare case of DRESS syndrome that reacted to cycloserine as well as isoniazid. Development of coreactivity to other drugs should be differentiated with a flare-up reaction in the management of DRESS syndrome.
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially fatal drug-induced systemic hypersensitivity response characterized by erythematous eruption, fever, leukocytosis with eosinophilia, and internal organ involvement. Antitubercular agents are potential causative agents for DRESS syndrome but difficult to verify as a culprit drug, since antitubercular agents are coadministered as a combination regimen. A 42-year-old female with endobronchial tuberculosis was diagnosed with DRESS syndrome after 4-week treatment of isoniazid, rifampicin, ethambutol, and pyrazinamide with prednisolone 50 mg. All the antitubercular agents were stopped and replaced with levofloxacin, cycloserine, p-aminosalicylic acid, and kanamycin. However, severe exacerbation of DRESS syndrome compelled the patient to discontinue the administration of the second-line antitubercular agents. Two months later, the patient underwent a patch test for all the antitubercular agents which had been used, and the results showed positivity to isoniazid and cycloserine. We report a rare case of DRESS syndrome that reacted to cycloserine as well as isoniazid. Development of coreactivity to other drugs should be differentiated with a flare-up reaction in the management of DRESS syndrome.
참고문헌 (23)
- Cacoub P, "The DRESS syndrome: a literature review", Am J Med, 124, pp.588~597 (2011)
- Nam YH, "Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised", Allergol Immunopathol (Madr), 43, pp.19~24 (2015)
- Y.-M. Ye, "Drug-specific CD4 + T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome", British Journal of Dermatology, 176(2), pp.378~386 (2017), Wiley-Blackwell[DOI]
- 최준혁, "에탐부톨에 의한 호산구증가증과 전신성 증상증후군 및 이소니아지드에 의한 자가면역간염의 동시발생", 대한소화기학회지, 67(5), pp.267~271 (2016), 대한소화기학회
- Arruti N, "Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS", J Investig Allergol Clin Immunol, 26, pp.119~120 (2016)
- 신규식, "항결핵제에 의한 호산구성다발근육염과 DRESS증후군", 대한신경과학회지, 34(2), pp.154~156 (2016), 대한신경과학회[DOI]
- Zhang SN, "Isoniazid-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome presenting as acute eosinophilic myocarditis", Intern Med, 54, pp.1227~1230 (2015)
- Toujani S, "Drug rash with eosinophilia and systemic symptoms to antituberculosis treatment", Tunis Med, 93, pp.590~593 (2015)
- 문성도, "이차 항결핵제에 약물과민반응증후군을 보인 다제내성 결핵 환자에서 급속 탈감작요법에 준한 항결핵제 재투여 1예", Allergy Asthma & Respiratory Diseases, 3(4), pp.297~301 (2015), 대한 소아알레르기 호흡기학회[DOI]
- 이진영, "A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment", Tuberculosis and Respiratory Diseases, 78(1), pp.27~30 (2015), 대한결핵및호흡기학회
- Thong BY, "A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy", Asia Pac Allergy, 4, pp.156~163 (2014)
- Shebe K, "Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man", Contact Dermatitis, 70, pp.125~127 (2014)
- Palmero D, "Difficult clinical management of anti-tuberculosis DRESS syndrome", Int J Tuberc Lung Dis, 17, pp.76~78 (2013)
- Kim JY, "A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome", Acta Derm Venereol, 93, pp.753~754 (2013)
- Kim JH, "A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid", Ann Allergy Asthma Immunol, 110, pp.118~119 (2013)
- N. Draz, "Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7)", Case Reports, 2013(jul31 1), pp.bcr2013010348~bcr2013010348 (2013), BMJ[DOI]
- Cheng J, "Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications", Pediatr Infect Dis J, 32, pp.1388~1390 (2013)
- Rodríguez R, "DRESS syndrome in a 19-year-old patient following the administration of first-line antituberculosis drugs", J Investig Allergol Clin Immunol, 22, pp.380~381 (2012)
- 정을식, "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Ethambutol and Rifampin", Infection and Chemotherapy, 44(3), pp.197~200 (2012), 대한감염학회[DOI]
- Lee SW, "Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing", J Investig Allergol Clin Immunol, 20, pp.631~632 (2010)
- 윤호준, "항결핵제에 의한 약물 유발성 과민 증후군으로 추정되는 2예", 대한피부과학회지, 45(6), pp.635~639 (2007), 대한피부과학회
- Joint Committee for the Revision of Korean Guidelines for Tuberculosis, "Korean guidelines for tuberculosis", Korea Centers for Disease Control and Prevention, ~ (2014)
- Tan SC, "Relapsing drug-induced hypersensitivity syndrome", Curr Opin Allergy Clin Immunol, 16, pp.333~338 (2016)